FLML Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-1.549|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-52.63M|
|Gross Profit Margin (Quarterly)||72.78%|
|Profit Margin (Quarterly)||-142.9%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM)||Upgrade|
SA Breaking News03/19 08:23
SA Breaking News03/19 08:07
|03/19/2015 10:00 EDT||Misc||Flamel Technologies Fourth Quarter Earnings Conference Call in 2014|
|03/19/2015||Earnings||Flamel Technologies Fourth Quarter Earnings in 2014 Release|
|10/31/2014 10:00 EDT||Misc||Flamel Technologies Third Quarter 2014 Results Conference Call|
|10/31/2014||Earnings||Flamel Technologies Third Quarter 2014 Results|
|07/29/2014 10:00 EDT||Misc||Flamel Technologies 2Q2014 Earning Conference Call|
|07/29/2014||Earnings||Second Quarter 2014 Earnings End July 2014|
|05/12/2014||Earnings||Flamel Technologies 1Q2014 Earning Result|
|05/12/2014||Misc||Flamel Technologies 1Q2014 Earning Conference Call|
FLML Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Flamel Technologies is up 39.10% over the last year vs S&P 500 Total Return up 13.76%, ANI Pharmaceuticals up 100.9%, and Concert Pharmaceuticals up 5.50%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for FLML
Portfolio Strategies Featuring FLML
Did Flamel Technologies make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.flamel.com
- IR Website: http://www.flamel.com/investors/
- HQ Country: France
- HQ State/Province: N/A
- Incorporation Country: France
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: March 31, 2015
- Est. Current Fiscal Year End: December 31, 2015
- Last Fiscal Quarter End: September 30, 2014
- Last Fiscal Year End: December 31, 2013
- Next Earnings Release: March 19, 2015
Flamel Technologies is a biopharmaceutical company mainly engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.
FLML Excel Add-In Codes
- Name: =YCI("FLML","name")
- Description: =YCI("FLML","description")
- Sector: =YCI("FLML","sector")
- Industry: =YCI("FLML","industry")
- Est. Current Fiscal Year End: =YCI("FLML","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.